Markku Pentikainen

Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

J. Hartikainen, M. Niemelä, T. Mäkikallio, 2019, The Lancet.

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

J. Hartikainen, H. Sørensen, M. Niemelä, 2016, The Lancet.

Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial

J. Hartikainen, H. Sørensen, M. Niemelä, 2016, The Lancet.

Randomized Trial of Cholesterol Lowering With Evolocumab for Cardiac Allograft Vasculopathy in Heart Transplant Recipients.

K. Karason, K. Broch, H. Eiskjær, 2024, JACC. Heart failure.